SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-011139
Filing Date
2022-04-28
Accepted
2022-04-28 16:37:46
Documents
2
Period of Report
2022-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165117817985016.html 3  
1 FORM 3 wf-form3_165117817985016.xml 3 1679
2 ROCAMBOLI POA ex-24.htm EX-24 3968
  Complete submission text file 0001628280-22-011139.txt   7120
Mailing Address C/OPARMOUNT CAPITAL 787 SEVENTH AVE 48TH FL NEW YORK NY 10019
Business Address
ROCAMBOLI STEPHEN (Reporting) CIK: 0001221451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 22867334

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations